[go: up one dir, main page]

GB201820451D0 - Compounds and their use for the treatment of alpha1-antitryspin deficiency - Google Patents

Compounds and their use for the treatment of alpha1-antitryspin deficiency

Info

Publication number
GB201820451D0
GB201820451D0 GBGB1820451.1A GB201820451A GB201820451D0 GB 201820451 D0 GB201820451 D0 GB 201820451D0 GB 201820451 A GB201820451 A GB 201820451A GB 201820451 D0 GB201820451 D0 GB 201820451D0
Authority
GB
United Kingdom
Prior art keywords
antitryspin
alpha1
deficiency
compounds
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1820451.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Z Factor Ltd
Original Assignee
Z Factor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Z Factor Ltd filed Critical Z Factor Ltd
Priority to GBGB1820451.1A priority Critical patent/GB201820451D0/en
Publication of GB201820451D0 publication Critical patent/GB201820451D0/en
Ceased legal-status Critical Current

Links

GBGB1820451.1A 2018-12-14 2018-12-14 Compounds and their use for the treatment of alpha1-antitryspin deficiency Ceased GB201820451D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1820451.1A GB201820451D0 (en) 2018-12-14 2018-12-14 Compounds and their use for the treatment of alpha1-antitryspin deficiency

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1820451.1A GB201820451D0 (en) 2018-12-14 2018-12-14 Compounds and their use for the treatment of alpha1-antitryspin deficiency

Publications (1)

Publication Number Publication Date
GB201820451D0 true GB201820451D0 (en) 2019-01-30

Family

ID=65147127

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1820451.1A Ceased GB201820451D0 (en) 2018-12-14 2018-12-14 Compounds and their use for the treatment of alpha1-antitryspin deficiency

Country Status (1)

Country Link
GB (1) GB201820451D0 (en)

Similar Documents

Publication Publication Date Title
IL276398A (en) Combination therapy for the treatment of mastocytosis
IL272948A (en) Enpp1 inhibitors and their use for the treatment of cancer
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
ZA202103977B (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
IL271117B (en) Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
SI3672954T1 (en) Compounds, salts thereof and their use for the treatment of diseases
IL277749A (en) Pladienolide compounds and their use
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof
IL276482A (en) Compounds for the treatment of pain
GB201813312D0 (en) Compounds and their therapeutic use
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
GB201700692D0 (en) Novel compounds and their use in the treatment of schistosomiasis
GB201519557D0 (en) Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions
IL277805A (en) Use of gaboxadol in the treatment of substance use disorders
GB201918414D0 (en) Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
GB201918413D0 (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
ZA202207493B (en) Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB201918404D0 (en) Compounds and their use for the treatment of aplha1-antitrypsin deficiency
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
SG11202100269VA (en) Compounds for use in the treatment of fascioliasis
GB201918416D0 (en) Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
IL276228A (en) Compounds and compositions for the treatment of pain
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)